person

Henrik H.

Country
Sweden
Department
Magtarmmedicinska kliniken, IBD mottagningen, Universitetssjukhuset i Linköping

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
228
Sites with multiple studies

Has run more than one trial at 228 of 359 partner sites.

Specializations

Inflammatory Bowel Disease Management

This investigator specializes in treating inflammatory bowel disease, with particular emphasis on Crohn's disease and ulcerative colitis. Their research focuses on optimizing treatment strategies for patients with these chronic conditions.

  • Anti-TNF Treatment Optimization
  • Remission Maintenance Strategies
  • Biological Marker Assessment

The investigator's work includes evaluating treatment discontinuation protocols in patients achieving remission.

Novel Therapeutic Approaches

The investigator explores innovative treatment options for moderately to severely active Crohn's disease, including the evaluation of new pharmaceutical compounds and combination therapies.

  • Emerging Drug Development
  • Treatment Efficacy Assessment
  • Clinical Response Monitoring

Their research encompasses the investigation of novel therapeutic agents and their impact on disease activity indices.

Combination Therapy Studies

The investigator studies advanced therapeutic combinations, particularly focusing on dual-targeted therapies including vedolizumab and upadacitinib for inflammatory bowel conditions.

  • Comparative Treatment Efficacy
  • Endoscopic Outcome Assessment
  • Clinical Response Evaluation

Their work examines both clinical and endoscopic outcomes in combination therapy approaches.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.